Physician profile
Sara Beth Leitheiser
NPI 1346804960
$1,352.63
in general payments reported to CMS, 2019-2025
22 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.48 · 2021: $23.44 · 2022: $299 · 2023: $268 · 2024: $416 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.82 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $222.10 | 2024-2025 | Veozah |
| Baxter Healthcare | $125.00 | 2023 | Seprafilm, Adept |
| Myovant Sciences INC. | $124.84 | 2022 | |
| Coopersurgical, INC. | $102.94 | 2023-2025 | Paragard T 380a, Endosee, Paragard T 380a |
| Ethicon US, LLC | $97.45 | 2022 | |
| Mayne Pharma Commercial LLC | $73.90 | 2025 | |
| Sage Therapeutics, LLC | $68.52 | 2024-2025 | Zurzuvae |
| Millicent US INC | $65.80 | 2025 | Femlyv, Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $59.39 | 2024-2025 | Gardasil 9, Gardasil |
| Sumitomo Pharma America, INC. | $56.76 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $46.83 | 2024-2025 | Nexplanon |
| Amgen INC. | $45.89 | 2024-2025 | Evenity, Prolia |
| Hologic Sales and Service, LLC | $42.76 | 2021-2023 | Fetal Fibronectin Enzyme Immunoassay |
| Exeltis, USA INC. | $36.08 | 2023-2024 | Slynd |
| Abbvie INC. | $32.79 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $26.36 | 2024 | Bd Max System, Bd Max Instrument |
| Exact Sciences Corporation | $26.30 | 2024 | Cologuard Collection Kit |
| Avanos Medical | $24.48 | 2019 | |
| Boston Scientific Corporation | $22.46 | 2022 | |
| Abc Home Medical Supply, INC. | $21.36 | 2022 | |
| Pfizer INC. | $16.18 | 2023 | |
| Alexion Pharmaceuticals, INC. | $14.44 | 2023 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Leitheiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.